Oxidative haemolysis after administration of doxorubicin.
D000208:Acute Disease; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D004317:Doxorubicin / Q000009:adverse effects*; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications; D006801:Humans; D008297:Male; D008875:Middle Aged
D004317:Doxorubicin